Biotechnology from bench to business

• Follow GEN on:
• Log In / Register | Subscribe

Current Issue

Top Keywords

• ADME/Tox
• Angiogenesis
• Apoptosis
• Antibodies
• Biomanufacturing
• Biomarkers
• Bioreactors
• Biosimilars
• Biotherapeutics
• Cancer
• Cancer Stem Cells
• Cell Culture
• Cell-Based Assays
• Chromatography
• Contract Manufacturing
• Gene Expression
• Genetics
• Genomics
• Glycan Analysis
• HPLC
• Immunoassay
• Liquid Handling
• mAb Production
• mAb Therapeutics
• Microarrays
• Multiplexing
• Next-Generation Sequencing
• Peptide Therapeutics
• PCR
• Pharmacokinetics
• Protein Characterization
• Protein Expression
• Protein Production
• Protein Therapeutics
• qPCR
• Reagents
• RNA-Seq
• Sequencing
• Single-Use Systems
• Small Molecules
• Stem Cells
• Transfection
• Vaccines

Metabolic Diseases - Related Content

• GEN Articles
• Insight & Intelligence™
• GEN News Highlights
• GEN Podcasts
• BLOG Biotech
• GEN Polls

GEN articles

• Feature Articles: Exploiting HDAC Inhibition
  Cancer and Metabolic Diseases Represent Promising Applications
• Feature Articles: Treating T2DM with Early Insulin Therapy
  Lack of Comprehensive Patient Education Has Stymied Adoption of Beneficial Treatment Option
• Feature Articles: Search Intensifies for Diabetes Drugs
  Myriad of Compounds Intended to Stop the Progression of Metabolic Diseases Moves Through the Pipeline
• Feature Articles: Getting a Handle on Metabolic Disorders
  Targets and Methods Vary, but the End-Goal Is the Same—More Effective Therapeutics
• Financial Focus: Amylin Builds on the Success of Byetta
  Minor Label Changes and Approval of Once Weekly Version of Drug Are Anticipated

• MORE METABOLIC DISEASES RELATED GEN ARTICLES

Insight & intelligence™

• Regulatory Environment Warms Up to Obesity Drugs and Could Heat Up Market
  March 20, 2012
  With Vivus receiving a positive recommendation, analysts see CV risk as one that can be evaluated post-approval.
• NIH Updates Its Strategy to Combat Obesity
  April 20, 2011
  Research spending has been on the upswing, but so has the obesity epidemic.
• Sirtuins: Antiaging Medicines or Marketing?
  February 16, 2010
  GSK shelled out $720 million for Sirtris but admits that the new science needs validation.
• 2009 in Review: Headline-Making Stories in the Biotech Industry
  January 6, 2010
  Even though last year was marred by the economic crash, the life science sector showed significant progress.
• Obesity Therapies Show Lackluster Efficacy Results
  December 3, 2009
  A potential market of $10 billion annually in the U.S. alone is keeping companies in the race to develop better drugs.

• MORE METABOLIC DISEASES RELATED INSIGHT & INTELLIGENCE™

GEN news highlights

• FDA Clears Novo Nordisk’s Levemir for Diabetic Children Aged Two Years and Over
  
• Six Suitors Join Bristol-Myers in Considering a Bid for Amylin
  
• Multiplicom, ICAN, ICM to Develop Tests for Cardiovascular, Metabolic, and Neurological Diseases
  
• Islet Licenses Yale IP to Identify Beta Cell Death Before Diabetes Manifests
  
• Takeda’s Type 2 Diabetes Therapies Set Back Again by FDA
  

• MORE METABOLIC DISEASES RELATED GEN NEWS HIGHLIGHTS

GEN podcasts

• PROTEIN IMPORTANT IN DIABETES FOUND TO PLAY ROLE IN OTHER DISEASES
  Struan Grant, Ph.D., is Associate Director of the Center for Applied Genomics at the Children’s Hospital of Philadelphia and Assistant Professor of Pediatrics, Department of Pediatrics, University of Pennsylvania School of Medicine
• NOVEL CANCER THERAPY MAY ARISE FROM DWARF POPULATION STUDY
  - Interview with Valter D. Longo, Ph.D., Associate Professor, Gerontology and Alzheimer's Research, Biological Sciences, College of Letters Arts & Sciences, Leonard Davis School of Gerontology, University of Southern California
• ANTIBODY FIGHTS FAT
  - Interview with Kim Janda, Ph.D., Ely R. Callaway, Jr. Professor of Chemistry, Member of The Skaggs Institute for Chemical Biology, and Director of the Worm Institute of Research and Medicine, Scripps Research Institute
• BREATH TEST FOR DISEASE DIAGNOSIS
  - Interview with Masood Yousef, Ph.D., senior research assistant in the Welsh Centre for Printing and Coating, Swansea University School of Engineering
• LINKING CHANGES IN GENE NETWORKS TO DISEASE
  - Interview with Eric Schadt, Ph.D., Executive Scientific Director of Research Genetics for Rosetta Inpharmatics, Inc., a wholly-owned subsidiary of Merck & Co.

• MORE METABOLIC DISEASES RELATED GEN PODCASTS

BLOG biotech

• Emerging Insights into the Role of the Skeleton
  
• The Next Big Thing: An Obesity Initiative from the NIH
  
• GSK's "Unselfish" Documentary Finances
  
• The Obesity Epidemic - It's Your Fault (and yours, and yours...)
  

• VIEW BY SUBJECT | MORE METABOLIC DISEASES RELATED BLOG BIOTECH

GEN polls

• Vivus' Obesity Drug Development
  

• MORE METABOLIC DISEASES RELATED GEN POLLS

Home | Terms of Use | Privacy Statement | Legal